Patient-Reported Outcomes To Be Topic Of February Meeting
This article was originally published in The Pink Sheet Daily
FDA plans to issue a draft guidance on patient-reported outcomes, which will be the subject of a joint FDA/Mayo Clinic meeting Feb. 23-25.
You may also be interested in...
Document outlines the evaluation and development of appropriate PRO instruments to collect outcomes data that supports labeling claims.
Bayer’s kidney cancer drug brought in $25.2 mil. (€20 mil.) in the first quarter following its approval late last year.